Recurrent copy number variations in the human fungal pathogen Candida parapsilosis .
Anna SelmeckiPublished in: mBio (2023)
Candida parapsilosis is an opportunistic fungal pathogen with increasing incidence in hospital settings worldwide; however, we lack a comprehensive understanding of the mechanisms promoting its virulence and drug resistance. Bergin et al. systematically quantify the frequency and effect of copy number variation (CNV) across 170 diverse clinical and environmental isolates of C. parapsilosis (Bergin SA, Zhao F, Ryan AP, Müller CA, Nieduszynski CA, Zhai B, Rolling T, Hohl TM, Morio F, Scully J, Wolfe KH, Butler G, 2022, mBio, https://doi.org/10.1128/mbio.01777-22). Using a combination of both short- and long-read whole genome sequencing techniques, they determine the structure and copy number of two CNVs that arose recurrently throughout the evolution of these isolates. Each CNV predominantly amplifies one coding sequence ( ARR3 or RTA3 ); however, the amplitude and recombination breakpoints are variable across the isolates. Amplification of RTA3 correlates with drug resistance and deletion causes drug susceptibility. This study highlights the need for further research into the mechanisms and dynamics of CNV formation and the impact of these CNVs on virulence and drug resistance across diverse fungal pathogens.
Keyphrases
- copy number
- candida albicans
- biofilm formation
- mitochondrial dna
- antimicrobial resistance
- pseudomonas aeruginosa
- escherichia coli
- genome wide
- genetic diversity
- staphylococcus aureus
- endothelial cells
- dna methylation
- risk factors
- healthcare
- dna damage
- transcription factor
- cystic fibrosis
- adverse drug
- dna repair
- protein kinase
- gram negative
- risk assessment
- multidrug resistant
- climate change
- acute care
- life cycle